In contrast, with mitochondrial myopathy or sarcopenia, GDF15 levels remain chronically elevated, presumably resulting in vastly different biological outcomes, similar to most metabolic hormones, where chronic hypo- or hyper-physiological levels are implicated in disease states. The gene discussed is GDF15; the disease is sarcopenia.